Immunocore

NASDAQ: IMCR · Real-Time Price · USD
32.94
-0.12 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
32.88
-0.17%
After-hours: Aug 15, 2025, 04:10 PM EDT

Immunocore Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
356.14M 333.58M 310.2M 331.79M 314.16M 299.25M 283.8M 226.23M 204.8M 176.32M 143.74M 102.27M 66.99M 40.72M 26.52M 27.35M 28.07M 30.13M
Cost of Revenue
2.65M 3.32M 2.73M 2.15M 1.97M 1.39M 1.36M 1.72M 1.51M 426.02K 454K 345K 282K 248K n/a n/a n/a n/a
Gross Profit
353.5M 330.26M 307.47M 329.63M 312.19M 297.86M 282.44M 224.51M 203.29M 175.89M 143.28M 101.92M 66.71M 40.48M 26.52M 27.35M 28.07M 30.13M
Operating Income
-46.45M -47.59M -70.46M -76.8M -69.15M -73.1M -68.11M -64.64M -72.8M -66.6M -61.57M -77.08M -99.01M -119.74M -135.16M -117.49M -109.96M -95.95M
Interest Income
19.59M 21.57M 25.64M 28.45M 27.57M 25.6M 20.48M 14.98M 10.43M 6.27M 3.15M 732.04K 143.04K 37.04K 49.04K 63K 422K 632K
Pretax Income
-22.34M -22.77M -52.94M -60.38M -64.33M -71.84M -68.1M -58.92M -56.07M -46.71M -44.15M -60.25M -97.49M -124.99M -140.93M -122.78M -114.14M -99.28M
Net Income
-20.31M -21.63M -51.09M -53.73M -60.15M -66.36M -62.57M -61.35M -57.44M -45.73M -41.22M -55.41M -91.77M -118.61M -131.52M -111.01M -100.24M -84.49M
Selling & General & Admin
160.84M 156.69M 155.78M 170.59M 148.42M 155.38M 157.26M 143.27M 155.79M 134.7M 113.64M 94.87M 89.03M 88.32M 88.4M 78.2M 67.87M 56.32M
Research & Development
239.1M 221.16M 222.15M 235.95M 221.71M 207.07M 184.77M 137.26M 122.03M 105.75M 89.17M 82.1M 75.6M 71.92M 73.23M 70.4M 74.01M 73.92M
Other Expenses
n/a n/a -190K -190K -190K -190K -401.72K -403.72K 560.28K 1.64M 2.04M 1.96M 1.02M -98K -15K -668K -748K -1.05M
Operating Expenses
399.94M 377.85M 377.93M 406.54M 370.13M 362.45M 342.03M 280.53M 278.78M 242.49M 204.85M 179M 165.72M 160.22M 161.68M 147.93M 141.13M 129.18M
Interest Expense
11.29M 18.61M 18.83M 12.19M 9.18M 6.17M 4.18M 7.02M 7.49M 7.61M 7.69M 6.37M 5.9M 5.79M 6.32M 5.57M 4.82M 4.17M
Selling & Marketing Expenses
-13.05M n/a n/a 41.87M 30.25M 17.2M 17.2M n/a 7.47M 15.66M 15.66M 15.66M 8.19M n/a n/a n/a n/a n/a
Cost & Expenses
402.59M 381.17M 380.66M 408.69M 372.11M 363.84M 343.4M 282.25M 280.3M 242.92M 205.31M 179.34M 166.01M 160.47M 161.68M 147.93M 141.13M 129.18M
Income Tax Expense
-5.35M -3.26M -1.84M -6.65M -4.18M -5.47M -5.54M 2.44M 1.37M -974.29K -2.92M -4.84M -5.72M -6.38M -9.4M -11.77M -13.91M -14.78M
Shares Outstanding (Basic)
50.29M 50.09M 49.99M 50.02M 50.01M 49.88M 48.89M 54.16M 48.69M 48.18M 46.67M 51.44M 43.94M 43.87M 43.67M 43.67M 43.79M 38.45M
Shares Outstanding (Diluted)
50.29M 51.95M 49.99M 52.81M 50.01M 49.88M 48.89M 54.16M 48.69M 48.18M 46.67M 51.44M 43.94M 43.87M 43.86M 43.8M 43.79M 38.45M
EPS (Basic)
-0.4 -0.43 -1.02 -1.09 -1.21 -1.35 -1.29 -1.29 -1.21 -0.98 -0.92 -1.28 -2.1 -2.71 -3.1 -2.69 -2.61 -2.49
EPS (Diluted)
-0.4 -0.43 -1.02 -1.09 -1.21 -1.35 -1.29 -1.29 -1.22 -0.99 -0.93 -1.29 -2.1 -2.71 -3.1 -2.69 -2.61 -2.49
EBITDA
-10.47M -11.61M -41.76M -44.04M -51.82M -50.26M -47.02M -53.53M -48.41M -39.31M -37.13M -49.71M -87.19M -114.55M -129.83M -120.4M -112.26M -97.56M
EBIT
2.54M -3.83M -33.77M -44.02M -51.84M -61.02M -58.09M -58.72M -54M -45.33M -43.87M -68.28M -105.99M -133.61M -149.02M -129.36M -121.47M -107.25M
Depreciation & Amortization
1.87M 2.86M 3.02M 3.16M 3.79M 4.88M 5.05M 6.27M 6.08M 5.63M 6.13M 6.51M 6.75M 6.88M 7.01M 7.62M 7.86M 8.34M